DK0904067T3 - Transdermalt indgivet dextromethorpan som hostestillende middel - Google Patents

Transdermalt indgivet dextromethorpan som hostestillende middel

Info

Publication number
DK0904067T3
DK0904067T3 DK97915801T DK97915801T DK0904067T3 DK 0904067 T3 DK0904067 T3 DK 0904067T3 DK 97915801 T DK97915801 T DK 97915801T DK 97915801 T DK97915801 T DK 97915801T DK 0904067 T3 DK0904067 T3 DK 0904067T3
Authority
DK
Denmark
Prior art keywords
dextromethorpane
transdermally administered
cough suppressant
morphanin
prodrugs
Prior art date
Application number
DK97915801T
Other languages
English (en)
Inventor
Ulla Hoeck
Bo Kreilgard
Helle Kristensen
Original Assignee
Pfizer Health Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Health Ab filed Critical Pfizer Health Ab
Application granted granted Critical
Publication of DK0904067T3 publication Critical patent/DK0904067T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK97915801T 1996-04-23 1997-03-21 Transdermalt indgivet dextromethorpan som hostestillende middel DK0904067T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9601528A SE9601528D0 (sv) 1996-04-23 1996-04-23 Transdermally administered dextromethorphan as antitissue agent
PCT/SE1997/000484 WO1997039742A1 (en) 1996-04-23 1997-03-21 Transdermally administered dextromethorphan as antitussive agent

Publications (1)

Publication Number Publication Date
DK0904067T3 true DK0904067T3 (da) 2005-03-14

Family

ID=20402295

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97915801T DK0904067T3 (da) 1996-04-23 1997-03-21 Transdermalt indgivet dextromethorpan som hostestillende middel

Country Status (14)

Country Link
US (1) US6335030B1 (da)
EP (1) EP0904067B1 (da)
JP (1) JP2000509037A (da)
AT (1) ATE284206T1 (da)
AU (1) AU714942B2 (da)
CA (1) CA2251966C (da)
DE (1) DE69731882T2 (da)
DK (1) DK0904067T3 (da)
ES (1) ES2234012T3 (da)
NZ (1) NZ332215A (da)
PT (1) PT904067E (da)
SE (1) SE9601528D0 (da)
WO (1) WO1997039742A1 (da)
ZA (1) ZA973444B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6846495B2 (en) * 1999-01-11 2005-01-25 The Procter & Gamble Company Compositions having improved delivery of actives
DE19901085C2 (de) * 1999-01-14 2003-12-18 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einer selbstklebenden Matrix, enthaltend organische Säure-Additionssalze von Alkaloiden des Morphin- bzw. Morphinantyps
GB9920167D0 (en) * 1999-08-25 1999-10-27 Avery Dennison Corp Pressure sensitive adhesive compositions
US7138133B2 (en) 2001-10-10 2006-11-21 The Procter & Gamble Company Orally administered liquid compositions
IL152574A (en) * 2002-10-31 2009-09-22 Transpharma Medical Ltd A system for passing through the skin of dry items or dried medicines
US7662404B2 (en) * 2002-10-31 2010-02-16 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized peptides and polypeptides
US7383084B2 (en) * 2002-10-31 2008-06-03 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized medications
US8133505B2 (en) * 2002-10-31 2012-03-13 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized medications
US8502681B2 (en) * 2005-06-20 2013-08-06 Biovigil, Llc Hand cleanliness
JP5015620B2 (ja) * 2007-01-30 2012-08-29 株式会社クラレ 皮膚外用剤
US20100160368A1 (en) * 2008-08-18 2010-06-24 Gregory Jefferson J Methods of Treating Dermatological Disorders and Inducing Interferon Biosynthesis With Shorter Durations of Imiquimod Therapy
BRPI0923164A2 (pt) 2008-12-19 2016-01-26 Graceway Pharmaceuticals Llc formulações de imiquimod com concentração de dosagem menos e regimes de dosagem curtos para o tratamento de ceratose actínica.
GEP20156418B (en) 2009-07-13 2016-01-11 Medicis Pharmaceutical Corp Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts
US8461102B2 (en) * 2010-03-02 2013-06-11 George E. Royster, JR. Methods and compositions for treating and preventing symptoms of hormonal variations
US10493049B2 (en) 2016-02-10 2019-12-03 Niracle LLC Applicator-based transdermal drug delivery system for administration of drugs in combination with topical formulations
TWI795446B (zh) * 2017-10-04 2023-03-11 美商神經治療股份有限公司 右旋美索芬(dextromethorphan)經皮輸送裝置
EP4125902A4 (en) * 2020-03-30 2024-05-22 Shinkei Therapeutics, Inc. TRANSDERMAL ADMINISTRATION OF DEXTROMETHORPHAN
US11844753B2 (en) 2021-11-08 2023-12-19 Weiyong Li Transdermal drug delivery system for delivering a drug to a patient
USD1094727S1 (en) 2022-07-16 2025-09-23 Aso Llc Transdermal toe patch
USD1077245S1 (en) 2022-07-16 2025-05-27 Aso Llc Transdermal foot patch
USD1097178S1 (en) 2022-07-16 2025-10-07 Aso Llc Transdermal foot patch

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3275510A (en) * 1966-09-27 Topical antitussive preparations
US2676177A (en) 1949-11-09 1954-04-20 Hoffmann La Roche Process for the preparation of optically active 3-methoxy-n-methyl morphinans and salts thereof
US4557934A (en) 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
US4645502A (en) * 1985-05-03 1987-02-24 Alza Corporation Transdermal delivery of highly ionized fat insoluble drugs
JPS6351327A (ja) * 1986-08-22 1988-03-04 Sato Seiyaku Kk 液状組成物
US4783450A (en) 1987-04-13 1988-11-08 Warner-Lambert Company Use of commercial lecithin as skin penetration enhancer
US4888354A (en) 1987-12-21 1989-12-19 Theratech, Inc. Skin penetration enhancement using free base and acid addition salt combinations of active agents
US4915950A (en) 1988-02-12 1990-04-10 Cygnus Research Corporation Printed transdermal drug delivery device
US5164406A (en) 1988-06-02 1992-11-17 Bristol-Myers Squibb Co. Method for enhancing transdermal penetration and compositions useful therein
EP0351897A3 (en) 1988-06-17 1990-03-21 The Procter & Gamble Company Skin penetration system for salts of amine-functional drugs
US5213568A (en) 1990-03-30 1993-05-25 Medtronic Inc. Activity controlled electrotransport drug delivery device
WO1991015261A1 (en) * 1990-03-30 1991-10-17 Medtronic, Inc. Activity controlled electrotransport drug delivery device
AU663857B2 (en) 1990-10-31 1995-10-26 Procter & Gamble Company, The Dextromethorphan antitussive compositions
GB9103302D0 (en) 1991-02-16 1991-04-03 Smithkline Beecham Plc Pharmaceutical formulations
JPH07500113A (ja) 1991-10-16 1995-01-05 リチャードソン、ビックス、インコーポレーテッド 薬物の改善された局所送達用の高皮膚浸透系
EG20380A (en) 1991-10-16 1999-02-28 Richardson Vicks Inc Enhanced skin penetration system for improved topical delivery of drugs
US5260066A (en) * 1992-01-16 1993-11-09 Srchem Incorporated Cryogel bandage containing therapeutic agent
US5756117A (en) * 1992-04-08 1998-05-26 International Medical Asscociates, Inc. Multidose transdermal drug delivery system
CN1134163A (zh) 1993-08-19 1996-10-23 辛勒斯治疗系统公司 水溶性压敏粘膜粘合剂和配备该粘合剂用于放置在有粘膜衬里的体腔内的器具

Also Published As

Publication number Publication date
ZA973444B (en) 1997-11-18
EP0904067B1 (en) 2004-12-08
JP2000509037A (ja) 2000-07-18
ES2234012T3 (es) 2005-06-16
DE69731882T2 (de) 2005-12-15
ATE284206T1 (de) 2004-12-15
CA2251966A1 (en) 1997-10-30
EP0904067A1 (en) 1999-03-31
SE9601528D0 (sv) 1996-04-23
WO1997039742A1 (en) 1997-10-30
US6335030B1 (en) 2002-01-01
PT904067E (pt) 2005-02-28
NZ332215A (en) 2000-09-29
DE69731882D1 (de) 2005-01-13
CA2251966C (en) 2008-01-15
AU2313297A (en) 1997-11-12
AU714942B2 (en) 2000-01-13

Similar Documents

Publication Publication Date Title
DK0904067T3 (da) Transdermalt indgivet dextromethorpan som hostestillende middel
NO944249L (no) Transdermal administrering av oksybutynin
NZ508526A (en) Opioid formulations for treating pain
WO2001013909A3 (en) Compositions and methods for treating opiate intolerance
PT1239849E (pt) Formulacoes farmaceuticas que compreendem resveratrol e a sua utilizacao
GR3032523T3 (en) Therapeutic preparation for the transdermal administration of active substances
MX9709644A (es) Dispositivo para el suministro transdermico por electrotransporte de fentanilo y sufentanilo.
MY100721A (en) Therapeutic agent.
NO20022014L (no) En fast oral kontrollert frigjorende doseringsform inneholdende hydrokodon
CA2341063A1 (en) Transdermally administered tolterodine as anti-muscarinic agent for the treatment of overactive bladder
ATE321529T1 (de) Dosierungsform für eine verzögerte und zunehmende wirkstoffsfreisetzung
DK1032376T3 (da) Anvendelse af benzhydrylsulfinylderivater til behandling af søvnighed af medicinal oprindelse
NO931766D0 (no) Topiske preparater for transdermal avlevering av forloeperlegemiddelderivater av morfin
AR039130A2 (es) Metodo de administracion de un agente farmaceuticamente activo a un ojo humano
YU49026B (sh) UPOTREBA 17 Гџ -(N-TERC-BUTILKARBAMOIL)-4-AZA-5-ALFA-ANDROST-1-3-ON ZA PROIZVODNJU LEKA ZA TRETIRANJE ANDROGENE ALOPECIJE
KR950703951A (ko) 광학적으로 순수한 r-케토로락을 포함하는 조성물과 무통과 해열치료에 이를 사용하는 방법(antipyretic and analgesic methods and compositions containing optically pure r-ketorolac)
ATE202926T1 (de) Pharmazeutische brausepräparate enthaltend bioabbaubare mikrokapseln zur kontrolierten wirkstofffreisetzung
TR200103613T2 (tr) Burun içinden tatbik edilen morfini içeren farmasötik formülasyonlar ve yöntemler.
ATE238778T1 (de) Transdermales therapeutisches system zur abgabe von hormonen
DK0538302T3 (da) Reduktion eller forhindring af hudirritation forårsaget af lægemidler
ES2135342B1 (es) Uso del raloxifeno o una sal o salvato del mismo en la preparacion de un medicamento para prevenir el cancer de mama.
SE9601527D0 (sv) Transdermally alministered acetylcysteine as mucolytic agent
MY126321A (en) Use of (alpha)-adrenoreceptor antagonists in the prevention and treatment of cancer.
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
ATE280575T1 (de) Transdermales therapeutisches system zur anwendung von candesartan